Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity.

Autor: Verma S; Division of Cardiac Surgery, Li Ka Shing Knowledge Institute of St Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, ON, Canada., Emerson S; Department of Biostatistics, University of Washington, Seattle, WA, USA., Plutzky J; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Kahn SE; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System, Seattle, WA, USA., Stensen S; Novo Nordisk A/S, Søborg, Denmark., Weeke PE; Novo Nordisk A/S, Søborg, Denmark., Musinga D; Novo Nordisk A/S, Søborg, Denmark., Poirier P; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec City, QC, Canada., Lingvay I; Department of Internal Medicine/Endocrinology and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA., Lincoff AM; Department of Cardiovascular Medicine, Cleveland Clinic, and Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
Jazyk: angličtina
Zdroj: Journal of the American College of Cardiology [J Am Coll Cardiol] 2024 Nov 06. Date of Electronic Publication: 2024 Nov 06.
DOI: 10.1016/j.jacc.2024.11.008
Databáze: MEDLINE